Latest Stans Energy Corp. (HREEF) Headlines Stans

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Stans Energy Corp. (HREEF) Headlines

Stans Energy Sued for Wrongful Dismissal
Business Wire - Wed Mar 05, 9:42AM CST
Stans Energy Corp. (TSX-V: HRE, OTCQX: HREEF)('Stans' or 'The Company') reports that its former Chief Financial Officer, Anna Kuranova, has sued the Company alleging a wrongful dismissal.

CORRECTING and REPLACING Stans Energy Corp Grants Options
Business Wire - Wed Mar 05, 9:23AM CST
First paragraph of release dated March 4, 2014 should read : "The option grant was approved by the board of directors on March 3, 2014" (instead of "March 3, 2013").

AMENDMENT to Correcting and Replacing Stans Energy Corp Grants Options
Filing Services Canada - Wed Mar 05, 9:23AM CST
Stans Energy Corp. (TSX-V: HRE, OTCQX: HREEF)

Correcting and Replacing: Stans Energy Corp Grants Options
Filing Services Canada - Tue Mar 04, 6:14PM CST
Stans Energy Corp. (HRE - TSX Venture, HREEF - OTCQX), ('Stans' or 'The Company') has granted on March 3, 2014, an aggregate of 2,700,000 incentive stock options to employees and directors of the company. Each stock option entitles the holder to purchase one common share of the Company for $0.07 per share until March 3, 2019. All options granted and any common shares issued upon the exercise of the options will be subject to a statutory four-month hold period expiring July 3, 2014. The option grant was approved by the board of directors on March 3, 2014 and is subject to regulatory approval.

Stans Energy Corp Grants Options
Business Wire - Mon Mar 03, 4:24PM CST
Stans Energy Corp (TSX-V: HRE, OTCQX: HREEF)('Stans' or 'The Company') has granted on March 3, 2014, an aggregate of 2,700,000 incentive stock options to employees and directors of the company. Each stock option entitles the holder to purchase one common share of the Company for $0.07 per share until March 3, 2019. All options granted and any common shares issued upon the exercise of the options will be subject to a statutory four-month hold period expiring July 3, 2014. The option grant was approved by the board of directors on October 23, 2013 and is subject to regulatory approval.

Stans Energy Files Q3 2013 Financial Statements
Business Wire - Thu Feb 27, 8:01AM CST
Stans Energy Corp. (TSX-V: HRE, OTCQX: HREEF), ("Stans" or the "Company"), is pleased to announce that it has completed and filed its Q3 2013 Financial Statements and accompanying MD&A, and CEO and CFO certificates with the Ontario Securities Commission ("Commission").

Russian Special Technical Export Licence Granted to Stans Energy Corp
Business Wire - Wed Feb 26, 12:51PM CST
Stans Energy Corp. (TSX-V: HRE, OTCQX: HREEF), ("Stans" or the "Company"), is pleased to announce that the Federal Service for Technical and Export Control of the Russian Federation ("FSTEC"), has granted a special export licence to Stans Energy.

Stans Energy Updates Status of Management Cease Trade Order
Business Wire - Fri Feb 21, 9:45AM CST
Stans Energy Corp. (TSX-V: HRE, OTCQX: HREEF), ("Stans" or the "Company"), announces that further to its application dated November 28, 2013 for a Management Cease Trade Order (MCTO), a temporary MCTO of the Ontario Securities Commission (the Commission) was issued on December 9, 2013. This MCTO prohibits all trading in and all acquisitions of the securities of the Company, by certain insiders, until two days after receipt by the Commission of all the required filings as noted in the Company's November 28, 2013 press release.

Stans Energy provides update on International Arbitration proceedings
M2 - Fri Feb 07, 4:28AM CST
Stans Energy Corp (TSX-V:HRE) (OTCQX:HREEF), a resource development company focused on progressing Heavy Rare Earth (HRE) properties, stated on Thursday that the Government of Kyrgyzstan has formed an inter-departmental working group in reaction to its ongoing International Arbitration claim.

Stans Energy Update on International Arbitration Proceedings
Business Wire - Thu Feb 06, 11:48AM CST
Stans Energy Corp. (TSX-V: HRE, OTCQX: HREEF), ("Stans" or the "Company"), announces that an inter-departmental working group has been formed by the Government of Kyrgyzstan in reaction to the Company's ongoing International Arbitration claim. A stated aim of this working group is to hold negotiations with Stans to reach an out-of-court settlement with the Company.

Stans Energy Announces Approval of Management Cease Trade Order Extension
Business Wire - Mon Feb 03, 10:44AM CST
Stans Energy Corp. (TSX-V: HRE, OTCQX: HREEF), ("Stans" or the "Company"), announces that its principal regulator, the Ontario Securities Commission (the "Commission") has issued a temporary order to extend the existing Management Cease Trade Order ("MCTO") to include its new Chief Financial Officer ("CFO"), Boris Aryev, following Mr. Aryev's appointment as CFO, and the Company's application for this extension.

Stans Energy Corp. (HREEF) Stock Research Links

HREEF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 0

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 197

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 173

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

BerGenBio Welcomes First Patient in Lung Cancer Study

Updated Category News Views 202

BerGenBio Embarks on Promising Lung Cancer Trial BerGenBio ASA, a clinical-stage biopharmaceutical company dedicated to combating serious diseases through innovative therapies, has reached a significant milestone in its journey. The company has successfully included the first patient in its clinical trial, focusing on the cutting-edge AXL kinase inhibitor known as...

Continue Reading
CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform

Updated Category News Views 247

CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform CIMG Inc. (NASDAQ: IMG), a dynamic group in the digital health and sales development sector, has officially launched its tokenized stock on the FlowStocks platform. This exciting development follows successful testing and represents a significant shift in how the company interacts with its investors. The new...

Continue Reading
Exploring the Impact of New SEC Leadership on Cryptocurrency

Updated Category News Views 179

New Era for Cryptocurrency Under SEC Leadership The recent changes at the Securities and Exchange Commission (SEC) under new leadership signal a transformative period for the cryptocurrency market. These developments could reshape the regulatory landscape, offering clarity and direction for investors and companies involved in the digital asset space. Understanding the...

Continue Reading
Shytoshi Kusama Transitions Roles: Shiba Inu's New Direction

Updated Category News Views 190

Shytoshi Kusama Transitions to New Leadership Role Shytoshi Kusama, the driving force behind the Shiba Inu ecosystem, has made a significant change by stepping down from his role as the lead visionary. This pivotal shift marks a transition to the position of lead ambassador, as he aims to spearhead global adoption more effectively. The Shift in Leadership Announcing his...

Continue Reading
BASF Shares Fall Following Proposed Dividend Cuts to Shareholders

Updated Category News Views 281

BASF (ETR:BASFN) just took a hit on its stock price after announcing some major shifts in its dividend policy. Shares plummeted by 2.9% to €44.035, all thanks to the company's new proposed minimum annual dividend of €2.25 per share for the upcoming 2024 business year. That’s a stark drop from the previous €3.40 per share they dished out in 2023—talk about making...

Continue Reading